⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Tata Aggressive Hybrid Fund - Growth - Direct Plan | Qsif Hybrid Long-Short Fund - Regular Plan - IDCW |
|---|---|---|
| Snapshot | ||
| AMC | Tata MF | QSIF |
| Category | Hybrid - Aggressive Hybrid Fund | Hybrid - Long-Short Fund |
| NAV | ₹473.60 (29 Oct 2026) | ₹12.61 (30 Oct 2026) |
| Rating | ★ | ★★★ |
| Benchmark | CRISIL Hybrid 35+65 - Aggressive Index | NIFTY 50 Hybrid Composite Debt 50:50 Index |
| Fund Manager | Satish Chandra Mishra | Sandeep Tandon |
| Inception | 01 Jan 2013 | 15 Oct 2025 |
| Returns | ||
| 1Y | -6.45% | 26.41% |
| 3Y | 8.01% | — |
| 5Y | 7.41% | — |
| Since Inception | 11.96% | 26.03% |
| Risk | ||
| 10.36 | 19.65 | |
| 1.12 | -0.48 | |
| 0.13 | 2.24 | |
| -1.04 | 39.13 | |
| 0.23 | 8.37 | |
| -10.06% | -2.41% | |
| Costs | ||
| Expense Ratio | 1.20% | 3.66% |
| Exit Load | 0.50% on or before 30D, Nil after 30D | 3% on or before 30D, NIL after 30D |
| Min SIP | ₹100 | ₹1,000 |
| Min Lumpsum | ₹5,000 | ₹10,00,000 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Tata MF98%
QSIF98%
1.7%Only 1.7% of holdings by weight are common between Tata MF and QSIF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingTata MFQSIF
Glaxosmithkline Pharmaceuticals Ltd.1.74%1.68%
Category context: Hybrid vs Hybrid. Open the full Screener →